PocketEdge
PocketEdge
NewsResearchPortfolioAdvisorsGuidesToolsAI
Ask AI
PocketEdge

Markets, research, advisors, guides, and tools. Understand what is happening, and what to do next.

Explore

  • News
  • Research
  • Advisors
  • Guides
  • Tools
  • Ask AI

© 2026 PocketEdge

PrivacyTermsLegal

Not investment advice. Verify with licensed professionals.

← All news

Desk note · industry · Packaged food / regulation

FSSAI sent Nestlé, Zydus, and Abbott notices over kids’ nutrition claims

On 21 October 2026, the Food Safety and Standards Authority of India issued enforcement notices to Nestlé India, Zydus Wellness, Abbott Healthcare, and others over promotional claims on infant and children’s products, including Complan, Lactogen Pro 1, and NAN Excella Pro Stage 1, days after proposing a ban on added sugars in infant foods up to six months.

22 Oct 2026 · 2 min read

Key takeaways

  • •FSSAI said on 21 October 2026 it issued notices over products including Complan, Lactogen Pro 1 Powder, NAN Excella Pro Stage 1, and infant milk substitutes where marketing allegedly breached food safety and advertising rules.
  • •Nestlé India was asked to substantiate digestive and immune-benefit claims on Lactogen Pro 1 and NAN Excella Pro Stage 1; the company said the post repeated September label issues it had already answered.
  • •Zydus Wellness was told to justify Complan claims such as “grow taller, faster” and “clinically proven 2X growth,” and regulators also flagged an Instagram reel on infant milk substitutes involving influencer Ira Fathima.

What's going on here?

On 21 October 2026, India’s food safety regulator issued fresh enforcement notices to large packaged-food companies over how they market products aimed at infants and children. The Food Safety and Standards Authority of India named Nestlé India, Zydus Wellness, Abbott Healthcare, and other parties in actions tied to items such as Complan, Lactogen Pro 1 Powder, and NAN Excella Pro Stage 1 infant formula. Regulators asked Nestlé to back claims about digestive and immune benefits on its infant powders. Zydus was told to provide scientific justification for Complan slogans promising faster height growth. FSSAI also moved against social media promotion of infant milk substitutes, citing an Instagram reel and issuing notices to influencer Ira Fathima alongside corporate respondents. Abbott said it was not involved in the reel and does not endorse the claims shown. The wave lands days after FSSAI proposed banning added sucrose and fructose in foods for babies up to six months and as the authority pushes harder on front-of-pack warning labels across the packaged food industry.

What does this mean?

When regulators question both pack copy and influencer posts, compliance is no longer a factory-floor checklist. Marketing teams must match what appears on the label, in the ad, on the e-commerce tile, and in a creator’s video. Infant formula and children’s nutrition sit in a tighter box because mis-stated health promises touch young consumers. Notices do not automatically pull products from shelves, but they signal that Delhi is willing to name global brands in public posts and demand evidence files. Nestlé’s response that September label issues were already answered shows companies will argue process, while FSSAI is building a paper trail ahead of possible penalties or reformulation orders. The pattern fits October’s wider sweep on infant sugars, warehouse raids, and misleading claims against other FMCG names.

Why should I care?

If you buy Complan, lactogen-style formula, or toddler drinks, compare pack claims with the legal product category in the fine print before you stock up for the festive pantry run. Parents should treat influencer reels on infant foods as advertising subject to the same rules as television spots. Retailers and quick-commerce operators may see more delistings or label refreshes on apps while cases move. Investors in listed food companies should watch whether notices convert into fines, recalls, or simply legal fees. Track company responses in exchange filings, court challenges to FSSAI’s label push, and whether smaller brands face the same scrutiny as multinationals.

More desk notes

Trade policy / exports

India’s trade minister says the EU pact could take effect in early 2027

Commerce minister Piyush Goyal said on 22 October 2026 that India’s proposed free-trade agreement with the European Union could become operational within four to five months after signing, with the deal expected to be inked before year-end during his visit to Germany.

Food delivery / quick commerce

Swiggy’s meal delivery unit made a record profit while Instamart losses widened

Swiggy reported on 22 October 2026 that September-quarter revenue rose 36% to about ₹7,571 crore and the consolidated net loss narrowed to ₹922 crore, as food delivery posted record adjusted core profit of about ₹349 crore while quick-commerce Instamart lost about ₹764 crore at the segment level amid heavier discounting and 69 new dark stores.

Quick-service restaurants / consumers

Sapphire Foods posted its strongest restaurant sales growth in four years

KFC and Pizza Hut operator Sapphire Foods India said on 22 October 2026 that September-quarter consolidated restaurant sales rose 20% year on year to about ₹885 crore, with KFC India same-store sales up 14% and adjusted EBITDA margin expanding 100 basis points to 7.1% even as the listed stock remained far below its 52-week high.

RBI / government borrowing

The RBI rejected every bid at Thursday’s treasury bill auction

On 22 October 2026, the Reserve Bank of India accepted no bids at the scheduled sale of short-dated government treasury bills, the first full cancellation in about seven months, as investors demanded higher yields amid a bond selloff, oil-linked inflation fears, and expectations of more rate hikes after October’s policy minutes.

Disclaimer

For informational purposes only. Not investment advice. Verify with filings and a licensed adviser.